Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
A long-term study sought to determine which factors help predict low adherence among young people with the virus.
Changes include new information about risks associated with dolutegravir during pregnancy and removal of older drugs owing to toxicities.
Following a group of Ethiopian children on antiretrovirals, researchers observed declining kidney function but improving liver enzymes.
A review of the major findings presented at the Annual Meeting of the American Association for the Study of Liver Diseases in San Francisco
Researchers argue that among children born to mothers with HIV, other factors such as the virus and substance use prompt such outcomes.
A recent study analyzed half a million visits to children hospitals by those 14 to 18 years old.
A new study found such young people typically hit standard adult milestones but often experience serious life challenges.
This is according to a survey conducted in South Africa.
The Elizabeth Glaser Pediatric AIDS Foundation continues its mission to end AIDS in children.
However, the majority of children with HIV in the 20 highest burden nations still aren’t on antiretrovirals.
This is according to a survey of parents and adolescents at a state fair in Minnesota.
Continuously providing such infants with antiretrovirals as early as possible limits the size of the reservoir.
However, the analysis that identified this connection is subject to various limitations.
However, this advantage over children not treated with effective combination ARV treatment appears to diminish over time.
A recent CDC analysis found that only a majority of children under the age of 13 were retained in routine medical care over time.
The child was treated with antiretrovirals for only 40 weeks starting at 9 weeks of age and has since maintained a fully suppressed virus.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.